医学临床研究
  2025年7月10日 星期四           首 页    |    期刊简介    |    编委会    |    投稿指南    |    期刊订阅    |    广告合作    |    留言板    |    联系我们    |    English
医学临床研究  2023, Vol. 40 Issue (12): 1909-1911    DOI: 10.3969/j.issn.1671-7171.2023.12.025
  论著 本期目录 | 过刊浏览 | 高级检索 |
FLT-1、YKL-40在呼吸道合胞病毒阳性患儿血清中的表达水平及其临床意义
叶文娟1, 王玉2*
1.西安医学院附属宝鸡医院儿科,陕西 宝鸡 721000;
2.商洛市妇幼保健院检验科,陕西 商洛 726000
The Expression Level and Clinical Significance of FLT-1 and YKL-40 in Serum of Children with Respiratory Syncytial Virus Positive
YE Wen-juan, WANG Yu
Department of Pediatric, Baoji Hospital Affiliated of Xi'an Medical College, Baoji Shaanxi 721000
全文: PDF (1365 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 【目的】探讨人血管内皮生长因子受体-1(FLT-1)、人甲壳质酶蛋白40(YKL-40)在呼吸道合胞病毒(RSV)阳性患儿血清中的表达水平及其临床意义。【方法】选择2019年3月至2021年4月西安医学院附属宝鸡医院收治的82例RSV阳性患儿,所有患儿均给予重组人干扰素α-2b注射治疗,根据临床疗效将RSV阳性患儿分为有效组和无效组。收集两组患儿的一般资料,采用Logistic多因素回归分析RSV阳性患儿临床疗效的影响因素,采用受试者工作特征(ROC)曲线分析血清FLT-1、YKL-40水平对RSV阳性患儿临床疗效的预测价值。【结果】本研究82例RSV阳性患儿中,有效组59例(71.95%),无效组23例(28.05%);有效组患儿年龄大于无效组,FLT-1、YKL-40水平均低于无效组,差异均具有统计学意义(P<0.05);多因素回归分析结果显示:患儿年龄小及血清FLT-1、YKL-40水平高均是RSV阳性患儿治疗无效的危险因素(P<0.05);ROC曲线分析结果显示:血清FLT-1及YKL-40水平预测RSV阳性患儿临床疗效的ROC曲线下面积(AUC)分别为0.803(95%CI:0.710~0.895)、0.778(95%CI:0.669~0.888)。【结论】血清FLT-1及YKL-40水平高的低龄RSV阳性患儿更易出现临床疗效不佳,二者对RSV阳性患儿的临床疗效具有一定的预测价值。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
叶文娟
王玉
关键词 呼吸道合胞病毒呼吸道感染/病毒学受体,血管内皮生长因子/血液软骨蛋白聚糖类/血液    
Abstract:【Objective】To investigate the expression level and clinical significance of human vascular endothelial growth factor receptor-1 (FLT-1) and human chitinase protein 40 (YKL-40) in the serum of children with respiratory syncytial virus (RSV) positive.【Methods】From March 2019 to April 2021, 82 children with RSV positive were treated in Baoji Hospital affiliated to Xi'an Medical College. All children were given recombinant human interferon α-2b For injection therapy, RSV positive children were divided into effective group and ineffective group according to the clinical efficacy. The general data of the two groups of children were collected, and the factors influencing the clinical efficacy of RSV positive children were analyzed by Logistic multivariate regression, and the predictive value of serum FLT-1 and YKL-40 levels on the clinical efficacy of RSV positive children was analyzed by using the subject working characteristic (ROC) curve.【Results】 Among 82 cases of RSV positive children in this study, 59 cases (71.95%) in the effective group and 23 cases (28.05%) in the ineffective group; The children in the effective group were older than those in the ineffective group, and the levels of FLT-1 and YKL-40 were lower than those in the ineffective group, the difference was statistically significant (P<0.05); Multivariate regression analysis showed that young children and high serum levels of FLT-1 and YKL-40 were risk factors for ineffective treatment in RSV positive children (P<0.05); The ROC curve analysis results showed that the area under the ROC curve (AUC) of serum FLT-1 and YKL-40 levels predicting the clinical efficacy of RSV positive children were 0.803(95%CI:0.710-0.895) and 0.778 (95%CI:0.669-0.888), respectively. 【Conclusion】The young RSV positive children with high serum FLT-1 and YKL-40 levels are more likely to have poor clinical efficacy, and both have certain predictive value for the clinical efficacy of RSV positive children.
Key wordsRespiratory Syncytial Viruses    Respiratory Tract Infections/VI    Receptors, Vascular Endothelial Growth Factor/BL    Aggrecans/BL
收稿日期: 2022-07-29     
中图分类号:  R725.631.2  
通讯作者: *E-mail:707751714@qq.com   
引用本文:   
叶文娟, 王玉. FLT-1、YKL-40在呼吸道合胞病毒阳性患儿血清中的表达水平及其临床意义[J]. 医学临床研究, 2023, 40(12): 1909-1911.
YE Wen-juan,WANG Yu. The Expression Level and Clinical Significance of FLT-1 and YKL-40 in Serum of Children with Respiratory Syncytial Virus Positive. JOURNAL OF CLINICAL RESEARCH, 2023, 40(12): 1909-1911.
链接本文:  
http://journal07.magtech.org.cn/yxlcyj/CN/10.3969/j.issn.1671-7171.2023.12.025     或     http://journal07.magtech.org.cn/yxlcyj/CN/Y2023/V40/I12/1909
版权所有 © 2013 医学临床研究杂志社  湘ICP备13012052号-1
办公地址:湖南省长沙市芙蓉区新军路43号煤炭大院主办公楼6楼621、623、632、636室 邮编:410011 电话(传真):0731-84824007 E-mail:jcr_cs.hn@vip.163.com
技术支持:北京玛格泰克科技发展有限公司 技术支持:support@magtech.com.cn